Neutralizing antibodies and complement-mediated antibody-dependent enhancement (C'-ADE) of human immunodeficiency virus infection in its vertical transmission

American Journal of Reproductive Immunology

Volumn 39, Issue 6, 1998, Pages 381-386

  Gras, Gabriel ^a,d   Beyssen, Véronique ^a   Tranchot Diallo, Juliette ^a   Parnet Mathieu, Françoise ^b   Lasfargues, Géraud ^c   Courpotin, Christian ^c   Dormont, Dominique ^a  

^a INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c ARMAND TROUSSEAU HOSPITAL   (France)

^d CE FAR DSV/DRM/SNV   (France)

Author keywords

Enhancing antibody; HIV; Neutralizing antibody; Pregnancy; Vertical transmission

Indexed keywords

COMPLEMENT; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; NEUTRALIZING ANTIBODY;

ANTIBODY DEPENDENT ENHANCEMENT; ARTICLE; CHILD; COMPLEMENT SYSTEM; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; INFANT; MAJOR CLINICAL STUDY; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; VERTICAL TRANSMISSION; VIRUS IMMUNITY; VIRUS TRANSMISSION;

EID: 0031835673     PISSN: 87558920     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0897.1998.tb00373.x     Document Type: Article

References (31)

1. di Maria H, Courpotin C, Rouzioux C, Cohen D, Rio D, Boussin F, Dormont D: Transplacental transmission of human immunodeficiency virus. Lancet 1986; 2:215-216.
2. Socié G, Gluckman E, Carosella E, Brossard Y, Lafon C, Brison O: Search for maternal cells in human umbilical cord blood by polymerase chain reaction amplification of two microsatellite sequences. Blood 1994; 83:340-344.
3. Petit T, Gluckman E, Carosella E, Brossard Y, Brison O, Socié G: A highly sensitive polymerase chain reaction method reveals the ubiquitous presence of maternal cells in human umbilical cord blood. Exp Hematol 1995; 23:1601-1605.
4. David JFE, Autran B, Tran HC, Menu E, Raphaël M, Debré P, et al.: Human trophoblast cells express CD4 and are permissive for productive infection with HIV-1. Clin Exp Immunol 1992; 88:10-16.
5. Kesson AM, Fear WR, Kazazi F, Mathijs JM, Chang J, King NJ, et al.: Human immunodeficiency virus type 1 infection of human placental macrophages in vitro. J Infect Dis 1993; 168:571-579.
6. Backe E, Jimenez E, Unger M, Schafer A, Jauniaux E, Vogel M: Demonstration of HIV-1 infected cells in human placenta by in situ hybridization and immunostaining. J Clin Pathol 1992;45:871-874.
7. Briant L, Wade CM, Puel J, Brown AJ, Guyader M: Analysis of envelope sequence variants suggests multiple mechanisms of mother-to-child transmission of human immunodeficiency virus type 1. J Virol 1995; 69:3778-3788.
8. Mulder-Kampinga GA, Simonon A, Kuiken CL, Dekker J, Scherpbier JH, van-de-Peere P, et al.: Similarity in env and gag genes between genomic RNAs of human immunodeficiency virus type 1 (HIV-1) from mother and infant is unrelated to time of HIV-1 RNA positivity in the child. J Virol 1995; 69:2285-2296.
9. Scarlatti G, Leitner T, Hodara V, Halapi E. Rossi P, Alvert J, et al.: Neutralizing antibodies and viral characteristics in mother-to-child transmission of HIV-1. AIDS 1993; 7:S45-S48.
10. Roques P, Humbert M, Dormont D: Neonatal diagnosis of HIV infection. Lancet 1991; 338:631.
11. Roques P, Courpotin C, Nanva R, Marcé D, Parnet-Mathieu F, Hervé F, et al.: Prospective study of HIV-1 vertical transmission IV. Four years of diagnostic. Proceedings of the 2nd International Conference on HIV in Children and Mothers; Sept. 7-10, 1993. Edinburgh. UK. p. 31.
12. Roques PA, Gras G, Parnet-Mathieu F, Mabondzo AM, Dollfus C, Narwa R, et al.: Clearance of HIV infection in 12 perinatally infected children: Clinical, virological and immunological data. AIDS 1995; 9:F19-F26.
13. Roques P, Marce D, Courpotin C, Parnet-Mathieu F, Herve F, Boussin FD, et al.: Correlation between HIV provirus burden and in utero transmission. AIDS 1993; 7:S39-S43.
14. Narwa R, Roques P, Courpotin C, Parnet-Mathieu F, Boussin F, Roane A, et al.: Characterization of human immunodeficiency virus type 1 p17 matrix protein motifs associated with mother-to-child transmission. J Virol 1996; 70:4474-4483.
15. Van-Rompay KK, Otsyula MG, Tarara RP, Canfield DR, Berardi CJ, McChesney MB, et al.: Vaccination of pregnant macaques protects newborns against mucosal simian immunodeficiency virus infection. J Infect Dis 1996; 173:1327-1335.
16. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M: Rapid turnover of plasma virions and CD4 lymphocytes in HI-1 infection. Nature 1995; 373:123-126.
17. Michael NL, Chang G, Ehrenberg PK, Vahey MT, Redfield RR: HIV-1 proviral genotypes form the peripheral blood mononuclear cells of an infected patient are differentially represented in expressed sequences. J Acquir Immune Defic Synd 1993; 6:1073-1085.
18. Mabondzo A, Rouvier P, Raoul H, Le-Naour R, Courpotin C, Herve F, et al.: Relationships between humoral factors in HIV-1-infected mothers and the occurrence of HIV infection in their infants. Clin Exp Immunol 1995; 102:476-480.
19. Kliks SC, Wara DW, Landers DV, Levy JA: Features of HIV-1 that could influence maternal-child transmission. JAMA 1994; 272:467-474.
20. Toth FD, Mosborg-Peterson P, Kiss J, Aboagye-Mathiesen G, Zdravkovic M, Hager H, et al.: Antibody-dependent enhancement of HIV-1 infection in human term syncytiotrophoblast cells cultured in vitro. Clin Exp Immunol 1994; 96:389-394.
21. Heath SL, Grant Tew J, Tew JG, Szakal AK, Burton GF: Follicular dendritic cells and human immunodeficiency virus infectivity. Nature 1995; 377:740-744.
22. Khouri YF, McIntosh K, Cavacini L, Posner M, Pagano M, Tuomala R, et al.: Vertical Transmission of HIV-1. Correlation with maternal viral load and plasma levels of CD4 binding site anti-gp 120 antibodies. J Clin Invest 1995; 95:732-737.
23. De-Rossi A, Zanotto C, Mammano F, Ometto L, Del-Mistro A, Chieco-Bianchi L: Pattern of antibody response against the V3 loop in children with vertically acquired immunodeficiency virus type 1 (HIV-1) infection. AIDS Res Hum Retroviruses 1993;9:221-228.
24. Husson RN, Lan Y, Kojima E, Venzon D, Mitsuya H, McIntosh K: Vertical transmission of human immunodeficiency virus type 1: Autologous neutralizing antibody, virus load, and virus phenotype. J Pediatr 1995; 126:865-871.
25. Scarlatti G, Jansson M: Mother-to-child transmission of HIV-1. Curr Opin Infect Dis 1995;8:59-65.
26. Jansson M, Wahren B, Scarlatti G, Principi N, Lombardi V, Livadiotti S, et al.: Patterns of immunoglobulin G subclass reactivity to HIV-1 envelope peptides in children born to HIV-1-infected mothers. AIDS 1992; 6:365-371.
27. Ugen KE, Goedert JJ, Boyer J, Refaeli Y, Frank I, Williams WV, et al.: Vertical transmission of human immunodeficiency virus (HIV) infection. Reactivity of maternal sera with glycoprotein 120 and 41 peptides from HIV type 1. J Clin Invest 1992; 89:1923-1930.
28. Goedert JJ, Dublin S: Perinatal transmission of HIV type 1: Association with maternal anti-HIV serological reactiv- ity. Mothers and Infants Cohort Study and the HIV-1 Perinatal Serology Work Group. AIDS Res Hum Retroviruses 1994; 10:1125-1134.
29. Rubinstein A, Goldstein H, Calvelli T, Devash Y, Rubinstein R, Soeiro R, et al.: Maternofetal transmission of human immunodeficiency virus-1 : The role of antibodies to the V3 primary neutralizing domain. Pediatr Res 1993; 33:S78-S79.
30. Lombardi V, Moschese V, Scarlatti G, Wahren B, Jansson M, Wigzell H, et al.: .Maternal markers affecting the risk of vertical transmission of HIV. Arch AIDS Res 1991 : V:49-52.
31. Ayyavoo V, Ugen KE, Fernandas LS, Goedert JJ, Rubinstein A, Williams WV, et al.: Analysis of genetic heterogeneity, antigenicity, and biological characteristics of HIV-1 in a maternal transmitter and nontransmitter patient pair. DNA Cell Biol 1996; 15:571-580.